C-Pyrazole A2A Receptor Agonists
    11.
    发明申请
    C-Pyrazole A2A Receptor Agonists 审中-公开
    C-吡唑A2A受体激动剂

    公开(公告)号:US20100081810A1

    公开(公告)日:2010-04-01

    申请号:US12491791

    申请日:2009-06-25

    IPC分类号: C07D473/34

    CPC分类号: C07H19/16

    摘要: 2-adenosine C-pyrazole compounds having formula (a) and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.

    摘要翻译: 具有式(a)的2-腺苷C-吡唑化合物和使用该化合物作为A2A受体激动剂的方法,用于刺激哺乳动物冠状血管扩张用于治疗目的和用于成像心脏的目的。

    N6 heterocyclic 8-modified adenosine derivatives
    14.
    发明授权
    N6 heterocyclic 8-modified adenosine derivatives 有权
    N6杂环8修饰腺苷衍生物

    公开(公告)号:US06294522B1

    公开(公告)日:2001-09-25

    申请号:US09454485

    申请日:1999-12-03

    IPC分类号: A61K3170

    CPC分类号: C07H19/16

    摘要: N6 heterocyclic 8 modified adenosine derivatives that are selective, partial or full adenosine A1 receptor partial or full agonists, and as such, are useful for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals, and especially in humans.

    摘要翻译: 作为选择性,部分或全部腺苷A1受体部分或全部激动剂的N6杂环8修饰的腺苷衍生物,因此可用于改善心脏活动,修饰脂肪细胞功能,治疗中枢神经系统疾病,以及治疗哺乳动物的糖尿病病症和肥胖症 ,特别是在人类。

    C-pyrazole 2A A receptor agonists
    15.
    发明授权
    C-pyrazole 2A A receptor agonists 有权
    吡唑2AA受体激动剂

    公开(公告)号:US06214807B1

    公开(公告)日:2001-04-10

    申请号:US09338327

    申请日:1999-06-22

    IPC分类号: A61K3170

    CPC分类号: C07H19/16

    摘要: 2-adenosine C-pyrazole compositions having the following formula: and methods for using the compositions as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.

    摘要翻译: 具有下式的2-腺苷C-吡唑组合物:以及用于作为A2A受体激动剂的组合物用于刺激哺乳动物冠状血管扩张用于治疗目的和用于成像心脏的方法。